189 related articles for article (PubMed ID: 24292682)
1. MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells.
Gong C; Qu S; Liu B; Pan S; Jiao Y; Nie Y; Su F; Liu Q; Song E
Oncogene; 2015 Jan; 34(1):84-93. PubMed ID: 24292682
[TBL] [Abstract][Full Text] [Related]
2. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
4. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Lee J; Kim HE; Song YS; Cho EY; Lee A
Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
6. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
8. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
9. TGF-β upregulates miR-181a expression to promote breast cancer metastasis.
Taylor MA; Sossey-Alaoui K; Thompson CL; Danielpour D; Schiemann WP
J Clin Invest; 2013 Jan; 123(1):150-63. PubMed ID: 23241956
[TBL] [Abstract][Full Text] [Related]
10. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
11. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
Li X; Zeng X
Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.
Kong W; Yang H; He L; Zhao JJ; Coppola D; Dalton WS; Cheng JQ
Mol Cell Biol; 2008 Nov; 28(22):6773-84. PubMed ID: 18794355
[TBL] [Abstract][Full Text] [Related]
13. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
14. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.
Yu Y; Wang Y; Ren X; Tsuyada A; Li A; Liu LJ; Wang SE
Mol Cancer Res; 2010 Dec; 8(12):1633-42. PubMed ID: 21047769
[TBL] [Abstract][Full Text] [Related]
15. miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells.
Yu D; Shin HS; Lee YS; Lee YC
Lab Invest; 2014 Dec; 94(12):1370-81. PubMed ID: 25286029
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-106b suppresses the growth of human glioma cells.
Zhang A; Hao J; Wang K; Huang Q; Yu K; Kang C; Wang G; Jia Z; Han L; Pu P
J Neurooncol; 2013 Apr; 112(2):179-89. PubMed ID: 23377830
[TBL] [Abstract][Full Text] [Related]
17. A positive TGF-β/miR-9 regulatory loop promotes the expansion and activity of tumour-initiating cells in breast cancer.
Liu Y; Chen Y; Zhao Q; Xie T; Xiang C; Guo Q; Zhang W; Zhou Y; Yuan Y; Zhang Y; Xi T; Li X; Zheng L
Br J Pharmacol; 2023 Sep; 180(17):2280-2297. PubMed ID: 37060166
[TBL] [Abstract][Full Text] [Related]
18. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
Cai K; Wang Y; Bao X
J Exp Clin Cancer Res; 2011 Aug; 30(1):73. PubMed ID: 21819631
[TBL] [Abstract][Full Text] [Related]
19. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
20. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
